| Model Number |
RONYX20012UX |
| Medical Device Problem Codes |
Entrapment of Device (1212); Device Dislodged or Dislocated (2923); Positioning Problem (3009)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/12/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
An attempt was made to use one resolute onyx coronary drug eluting stent to treat a lesion.Negative prep was performed with no issues.The lesion was pre-dilated.The device did not pass through a previously deployed stent.Resistance was encountered when advancing the device.It was reported that the device failed to cross the lesion.When the stent was pulled back through the catheter, the stent unknowingly came off the balloon.Then, when an attempt was made to go up the catheter with a new different stent, this stent ended up tangling with the dislodged resolute onyx stent left in the catheter.The issue was spotted prior to deployment and both stents were removed safely from the patient.The patient is alive with no injury.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: the lesion was heavily tortuous and heavily calcified, with 90% stenosis located in the obtuse marginal (om) artery.Excessive force was not used during delivery.The stent being inserted to which the resolute onyx became entangled was a non-medtronic device.The resolute onyx stent got stuck in a non-medtronic hemostasis valve as it was being removed from the catheter.Resistance was noted during withdrawal, and excessive force was not used.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: the catheter used during the procedure was an ebu shaped device.The stent got stuck on a balloon wire but was safetly removed through the catheter with no other intervention required.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: annex d codes.Correction: resistance was not noted during withdrawal of the device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: it was not realized that the stent had come off the balloon until the non-medtronic stent was advanced, and it was then noticed another stent had become lodged onto it.Upon removal from the non-medtronic hemostasis valve, the resolute onyx stent detached itself from the non-medtronic stent, and the got snagged on the non-medtronic hemostasis valve as it was being removed from the ebu catheter.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|